Why the Eclipx share price surged 16% on the ASX yesterday

The Eclipx Group Ltd (ASX: ECX) share price surged 16% higher yesterday to recover some of its heavy losses recorded in the last 2 weeks.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Eclipx Group Ltd (ASX: ECX) share price surged 16% higher yesterday to recover some of its heavy losses recorded in the last 2 weeks.

What drove the share price higher yesterday?

With no company-specific news released to the ASX yesterday, I think the latest surge could be a market correction after the last fortnight's declines and optimism regarding Eclipx's upcoming half-year results release.

On 25 March, Eclipx provided a second update on its financial position and overall wellbeing, including its compliance with debt covenants and terms with lenders.

On the dividend front, the company's Board of Directors confirmed it will not be paying an interim dividend following the release of its 31 March 2019 results.

Why is the Eclipx share price down 68.8% in 2019?

The vehicle fleet leasing company reported a net profit after tax and amortisation (NPATA) had fallen 42.4% compared to the first 5 months of FY18 and that it could not provide full-year guidance for FY19 at the moment.

The company also announced that its financial performance had "softened" since its 29 January 2019 update as Grays Industrial and Insolvency segments continue to underperform and that it is looking at divesting non-core assets.

Both Eclipx management and McMillan Shakespeare Ltd (ASX: MMS) announced that a planned merger was "unlikely" as McMillan pointed to several key issues in Eclipx's trading update including the NPATA decline and ongoing underperformance.

Is Eclipx a Buy?

Given how the company's share price has fallen in the first quarter, I think there's still too much heat in the market surrounding Eclipx.

When it comes to these sorts of situations, I take the view that there are traders and analysts who know a lot more about what's going on with Eclipx and therefore it's best not to try and jump in as a retail investor.

For the moment I'd be steering clear of Eclipx given the ongoing turbulence and checking out this top-rated stock in a $22 billion (and growing) industry instead.

Motley Fool contributor Lachlan Hall has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Man drawing an upward line on a bar graph symbolising a rising share price.
Share Gainers

Why Latin Resources, Newmont, Nick Scali, and ResMed shares are surging today

These ASX shares are ending the week strongly. But why?

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

Let's also take a look at what the various ASX sectors were doing this Wednesday.

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Argosy Minerals, Immutep, Pointsbet, and Regis Resources shares are racing higher

These shares are having a strong session on Wednesday. But why?

Read more »

Businessman smiles with arms outstretched after receiving good news.
Share Gainers

Here are the top 10 ASX 200 shares today

It was another strong showing from the share market today.

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Healthco Healthcare, Medadvisor, Ramsay Health Care, and Tamboran shares are rising

These shares are having a strong session. But why?

Read more »

drug capsule opening up to reveal dollar signs signifying rising asx share price
Share Gainers

If you invested $6,000 in Mesoblast shares a month ago you'd have $15,636 now!

Mesoblast shares have been on a tear this past month. But why?

Read more »

Smiling man working on his laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

It was back to the races for ASX shares today, in a confident start to the week.

Read more »

rising gold share price represented by a green arrow on piles of gold block
Share Gainers

Here are the top 10 ASX 200 shares today

It was a horrible way to end the trading week today for ASX investors.

Read more »